866-997-4948(US-Canada Toll Free)

United States Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

Published By :

GlobalData

Published Date : Jan 2017

Category :

Medical Equipments

No. of Pages : 488 Pages

United States Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

Summary

GlobalDatas new report, "United States Diabetes Care Devices Market Outlook to 2022", provides key market data on the United States Diabetes Care Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Glucose Monitoring and Insulin Delivery.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for Diabetes Care Devices market.
- Global corporate-level profiles of key companies operating within the United States Diabetes Care Devices market.
- Key players covered include LifeScan Inc, Medtronic plc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Diabetes Care Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Diabetes Care Devices Market, United States 11
3.1 Diabetes Care Devices Market, United States, Revenue ($m), 2008-2022 11
3.2 Diabetes Care Devices Market, United States, Revenue Mix ($m), 2015 12
3.3 Diabetes Care Devices Market, United States, Category Contribution by Revenue ($m), 2015 13
3.4 Diabetes Care Devices Market, United States, Revenue ($m), 2008-2015 14
3.5 Diabetes Care Devices Market, United States, Revenue ($m), 2015-2022 16
3.6 Diabetes Care Devices Market, United States, Volume (Units), 2008-2022 18
3.7 Diabetes Care Devices Market, United States, Volume (Units), 2008-2015 19
3.8 Diabetes Care Devices Market, United States, Volume (Units), 2015-2022 21
3.9 Diabetes Care Devices Market, United States, Company Share by Revenue ($m), 2015 23
4 Glucose Monitoring Market, United States 25
4.1 Glucose Monitoring Market, United States, Revenue Mix ($m), 2015 25
4.2 Glucose Monitoring Market, United States, Segment Contribution (%), 2015 26
4.3 Glucose Monitoring Market, United States, Revenue ($m), 2008-2015 27
4.4 Glucose Monitoring Market, United States, Revenue ($m), 2015-2022 29
4.5 Glucose Monitoring Market, United States, Volume (Units), 2008-2015 35
4.6 Glucose Monitoring Market, United States, Volume (Units), 2015-2022 37
4.7 Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), 2014-2015 43
4.8 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2015 44
5 Insulin Delivery Market, United States 46
5.1 Insulin Delivery Market, United States, Revenue Mix ($m), 2015 46
5.2 Insulin Delivery Market, United States, Segment Contribution (%), 2015 47
5.3 Insulin Delivery Market, United States, Revenue ($m), 2008-2015 48
5.4 Insulin Delivery Market, United States, Revenue ($m), 2015-2022 50
5.5 Insulin Delivery Market, United States, Volume (Units), 2008-2015 60
5.6 Insulin Delivery Market, United States, Volume (Units), 2015-2022 62
5.7 Insulin Delivery Market, United States, Distribution Share by Revenue ($m), 2014-2015 72
5.8 Insulin Delivery Market, United States, Company Share by Revenue ($m), 2015 73
6 Overview of Key Companies in United States, Diabetes Care Devices Market 75
6.1 Medtronic plc 75
6.2 Eli Lilly and Company 75
6.3 LifeScan Inc 75
6.4 Becton Dickinson and Co 76
6.5 Bayer HealthCare AG 76
6.6 Novo Nordisk A/S 76
6.7 Abbott Laboratories 77
6.8 Insulet Corp 77
6.9 DexCom Inc 77
6.10 F. Hoffmann-La Roche Ltd 77
6.11 Sanofi 78
6.12 Trividia Health Inc 78
7 Diabetes Care Devices Market Pipeline Products 79
8 Financial Deals Landscape 80
8.1 Acquisition 80
8.2 Debt Offerings 88
8.3 Equity Offerings 133
8.4 Partnerships 140
8.5 Private Equity 156
8.6 Venture Financing 157
9 Recent Developments 171
9.1 Corporate Communications 171
9.2 Financial Announcements 221
9.3 Government and Public Interest 398
9.4 Legal And Regulatory 401
9.5 Other Significant Developments 415
9.6 Product News 447
9.7 Strategy And Business Planning 459
10 Appendix 473
10.1 Research Methodology 474
10.2 GlobalData Consulting 476
10.3 Contact Us 476
10.4 Disclaimer 477

List of Table

1.1 List of Tables
Table 1: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, 2008-2022 22
Table 2: Diabetes Care Devices Market, United States, Category Contribution by Revenue ($m), 2015 24
Table 3: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 26
Table 4: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 28
Table 5: Diabetes Care Devices Market, United States, Volume (Units), 2008-2022 29
Table 6: Diabetes Care Devices Market, United States, Volume (Units), Historic, 2008-2015 31
Table 7: Diabetes Care Devices Market, United States, Volume (Units), Forecast, 2015-2022 33
Table 8: Diabetes Care Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2015 35
Table 9: Glucose Monitoring Market, United States, Segment Contribution (%), 2015 37
Table 10: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 39
Table 11: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 41
Table 12: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 43
Table 13: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 45
Table 14: Glucose Monitoring Market, United States, Volume (Units), Historic, 2008-2015 47
Table 15: Glucose Monitoring Market, United States, Volume (Units), Forecast, 2015-2022 49
Table 16: Blood Glucose Meters Market, United States, Volume (Units), Historic, 2008-2015 51
Table 17: Blood Glucose Meters Market, United States, Volume (Units), Forecast, 2015-2022 53
Table 18: Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015 54
Table 19: Glucose Monitoring Market, United States, Company Share by Revenue ($m), USD Constant, 2015 56
Table 20: Insulin Delivery Market, United States, Segment Contribution (%), 2015 58
Table 21: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 60
Table 22: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 62
Table 23: Insulin Pens Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 64
Table 24: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 66
Table 25: Insulin Pens Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 68
Table 26: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 70
Table 27: Insulin Delivery Market, United States, Volume (Units), Historic, 2008-2015 72
Table 28: Insulin Delivery Market, United States, Volume (Units), Forecast, 2015-2022 74
Table 29: Insulin Pens Market, United States, Volume (Units), Historic, 2008-2015 76
Table 30: Insulin Pumps Market, United States, Volume (Units), Historic, 2008-2015 78
Table 31: Insulin Pens Market, United States, Volume (Units), Forecast, 2015-2022 80
Table 32: Insulin Pumps Market, United States, Volume (Units), Forecast, 2015-2022 82
Table 33: Insulin Delivery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015 83
Table 34: Insulin Delivery Market, United States, Company Share by Revenue ($m), USD Constant, 2015 85
Table 35: Diabetes Care Devices Market Pipeline Products 90
Table 36: BioTelemetry Acquires Telcare Medical Supply and Associated Assets 91
Table 37: CRF Health Acquires Entra Health Systems 92
Table 38: Abbott Labs to Acquire Alere 93
Table 39: Liberty Medical Acquires Neighborhood Diabetes from Insulet for USD5 Million 95
Table 40: MannKind May Sell Itself 97
Table 41: Teleflex Acquires Nostix 98
Table 42: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million 99
Table 43: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million 101
Table 44: Abbott Labs Prices Public Offering of 2.35% Notes due 2019 for USD2.9 Billion 103
Table 45: Abbott Labs Prices Public Offering of 2.9% Notes due 2021 for USD2.85 Billion 105
Table 46: Abbott Labs Prices Public Offering of 3.4% Notes due 2023 for USD1.5 Billion 107
Table 47: Abbott Labs Prices Public Offering of 3.75% Notes due 2026 for USD3 Billion 109
Table 48: Abbott Labs Prices Public Offering of 4.75% Notes due 2036 for USD1.7 Billion 111
Table 49: Abbott Labs Prices Public Offering of 4.9% Notes due 2046 for USD3.3 Billion 113
Table 50: Pfizer Raises USD1 Billion in Public Offering of 1.7% Notes Due 2019 115
Table 51: Pfizer Raises USD1 Billion in Public Offering of 2.2% Notes Due 2021 117
Table 52: Pfizer Raises USD1.8 Billion in Public Offering of 3% Notes Due 2026 119
Table 53: Pfizer Raises USD1 Billion in Public Offering of 4% Notes Due 2036 121
Table 54: Pfizer Raises USD1.3 Billion in Public Offering of 4.125% Notes Due 2046 123
Table 55: Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes 125
Table 56: Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028 127
Table 57: Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028 129
Table 58: Insulet Raises Private Placement of Senior Notes for USD300 Million 131
Table 59: Pfizer Raises USD1.25 Billion in Public Offering of 1.2% Notes Due 2018 132
Table 60: Pfizer Raises USD0.85 Billion in Public Offering of 1.45% Notes Due 2019 134
Table 61: Pfizer Raises USD1.15 Billion in Public Offering of 1.95% Notes Due 2021 136
Table 62: Pfizer Raises USD1.25 Billion in Public Offering of 2.75% Notes Due 2026 138
Table 63: Pfizer Raises USD0.5 Billion in Public Offering of 4.4% Notes Due 2044 140
Table 64: Echo Therapeutics Raises USD3.4 Million in Second and Final Tranche of Private Placement of Notes and Warrants 142
Table 65: Echo Therapeutics Raises USD1.8 Million in First Tranche Private Placement of Notes and Warrants 143
Table 66: GI Dynamics to Raise USD1.2 Million in Private Placement of CDIs 144
Table 67: ConvaTec Raises USD1.8 Billion in IPO 145
Table 68: Mannkind Prices Shares Issue for USD50 Million 146
Table 69: Valeritas Raises USD25 Million in Private Placement of Shares 147
Table 70: Senseonics Raises USD45 Million in Public Offering of Shares 148
Table 71: PharmaCyte Biotech Raises USD1 Million in Private Placement of shares 150
Table 72: Defymed Enters into Agreement with Semma Therapeutics 151
Table 73: Becton, Dickinson Enters into Research Agreement with Juvenile Diabetes Research Foundation 152
Table 74: Thermo Fisher Scientific Enters into Agreement with Hamilton Storage Technologies 153
Table 75: WellDoc Enters into Agreement with LifeScan 154
Table 76: Sanofi and Verily Life Sciences Form Joint Venture 155
Table 77: JDRF Enters into Co-Development Agreement with Arecor 156
Table 78: Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 157
Table 79: Profil Institute for Clinical Research Enters into Agreement with mySugr 158
Table 80: Diasend Partners with Abbott Labs 159
Table 81: Medtronic and Qualcomm Life Enter into Co-Development Agreement 160
Table 82: InSpark Technologies Enters into Agreement with Atlanta Diabetes Associates and East Carolina Diabetes and Obesity Institute 161
Table 83: Metabolon Enters into Licensing Agreement with Synlab 162
Table 84: LifeScan Enters into Agreement with WellDoc 163
Table 85: Insulet Enters into Licensing Agreement with Mode AGC 164
Table 86: Senseonics Enters into Agreement with Diasend 165
Table 87: Insulet Enters into Co-Development Agreement with Eli Lilly 166
Table 88: Warburg Pincus to Invest in Hygiena 167
Table 89: Intuity Medical Raises USD40 Million in Series 3 Financing 168
Table 90: Bigfoot Biomedical Raises USD35.5 Million in Series A Financing 170
Table 91: Glooko Raises USD8 Million in Financing Round 171
Table 92: Dance Biopharm Raises USD0.625 Million in Venture Financing 172
Table 93: Eccrine Systems Raises USD4.56 Million in Venture Financing 173
Table 94: Common Sensing Raises USD1.6 Million in Financing Round 174
Table 95: Optiscan Biomedical Raises USD29.5 Million in Financing Round 175
Table 96: DexCom Raises USD7.2 Million in Venture Financing 176
Table 97: Livongo Health Raises USD44.5 Million in Series C Financing Round 177
Table 98: WellDoc Raises USD7.5 Million in Extended Series B Financing 179
Table 99: Epinex Diagnostics Raises USD0.1 Million in Venture Financing 180
Table 100: Bigfoot Biomedical Raises USD2.37 Million in Venture Financing 181

List of Chart

1.2 List of Figures
Figure 1: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, 2008-2022 22
Figure 2: Diabetes Care Devices Market, United States, Revenue Mix ($m), 2015 23
Figure 3: Diabetes Care Devices Market, United States, Category Contribution (%), 2015 24
Figure 4: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 25
Figure 5: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 27
Figure 6: Diabetes Care Devices Market, United States, Volume (Units), 2008-2022 29
Figure 7: Diabetes Care Devices Market, United States, Volume (Units), Historic, 2008-2015 30
Figure 8: Diabetes Care Devices Market, United States, Volume (Units), Forecast, 2015-2022 32
Figure 9: Diabetes Care Devices Market, United States, Company Share (%) 2015 34
Figure 10: Glucose Monitoring Market, United States, Revenue Mix ($m), 2015 36
Figure 11: Glucose Monitoring Market, United States, Segment Contribution (%), 2015 37
Figure 12: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 38
Figure 13: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 40
Figure 14: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 42
Figure 15: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 44
Figure 16: Glucose Monitoring Market, United States, Volume (Units), Historic, 2008-2015 46
Figure 17: Glucose Monitoring Market, United States, Volume (Units), Forecast, 2015-2022 48
Figure 18: Blood Glucose Meters Market, United States, Volume (Units), Historic, 2008-2015 50
Figure 19: Blood Glucose Meters Market, United States, Volume (Units), Forecast, 2015-2022 52
Figure 20: Glucose Monitoring Market, United States, Company Share (%) 2015 55
Figure 21: Insulin Delivery Market, United States, Revenue Mix ($m), 2015 57
Figure 22: Insulin Delivery Market, United States, Segment Contribution (%), 2015 58
Figure 23: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 59
Figure 24: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 61
Figure 25: Insulin Pens Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 63
Figure 26: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 65
Figure 27: Insulin Pens Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 67
Figure 28: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 69
Figure 29: Insulin Delivery Market, United States, Volume (Units), Historic, 2008-2015 71
Figure 30: Insulin Delivery Market, United States, Volume (Units), Forecast, 2015-2022 73
Figure 31: Insulin Pens Market, United States, Volume (Units), Historic, 2008-2015 75
Figure 32: Insulin Pumps Market, United States, Volume (Units), Historic, 2008-2015 77
Figure 33: Insulin Pens Market, United States, Volume (Units), Forecast, 2015-2022 79
Figure 34: Insulin Pumps Market, United States, Volume (Units), Forecast, 2015-2022 81
Figure 35: Insulin Delivery Market, United States, Company Share (%) 2015 84

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports